How does an alkaline gastric environment affect the chemical stability and absorption of Adderall (mixed amphetamine salts) and Vyvanse (lisdexamfetamine)?

Alkaline Gastric Environment Effects on Adderall and Vyvanse

Critical Pharmacokinetic Impact on Adderall (Mixed Amphetamine Salts)

An alkaline (basic) gastric environment significantly increases the absorption and bioavailability of Adderall by reducing ionization of amphetamine molecules, thereby enhancing passive diffusion across gastrointestinal membranes and decreasing urinary excretion. 1

Mechanism of Enhanced Absorption

• Gastrointestinal alkalinizing agents (such as sodium bicarbonate, antacids, or proton pump inhibitors) increase absorption of amphetamines by shifting the equilibrium toward the non-ionized, lipid-soluble form of the amphetamine molecule, which crosses biological membranes more readily 1

• The concentration of non-ionized amphetamine species increases in alkaline conditions, allowing greater passive diffusion from the gastrointestinal tract into systemic circulation 1

• Both gastrointestinal and urinary alkalinizing agents increase blood levels and potentiate the actions of amphetamines through complementary mechanisms—enhanced absorption and reduced renal clearance 1

Clinical Consequences of Alkalinization

• Urinary alkalinizing agents (acetazolamide, some thiazides) decrease urinary excretion by increasing the proportion of non-ionized amphetamine that undergoes tubular reabsorption rather than elimination 1

• The combined effect of increased absorption and decreased excretion can lead to unexpectedly high plasma concentrations, potentially causing excessive stimulation, cardiovascular effects (tachycardia, hypertension), insomnia, anxiety, or other dose-related adverse effects 1

• Peak amphetamine concentrations and duration of effect may be significantly prolonged when alkalinizing conditions are present, as demonstrated by studies showing amphetamine detection in urine for up to 47.5 hours post-dose under normal conditions—this window would extend further with alkalinization 2

Opposite Effect: Acidifying Agents

• Gastrointestinal acidifying agents (guanethidine, reserpine, glutamic acid hydrochloride, ascorbic acid, fruit juices) lower absorption of amphetamines by increasing ionization 1

• Urinary acidifying agents (ammonium chloride, sodium acid phosphate) increase the concentration of ionized amphetamine species, thereby increasing urinary excretion and lowering blood levels and efficacy 1

---

Minimal Impact on Vyvanse (Lisdexamfetamine)

Vyvanse is substantially less affected by gastric pH changes because it is a therapeutically inactive prodrug that requires enzymatic hydrolysis in the blood—not gastric absorption—to release active d-amphetamine. 3, 4

Prodrug Protection Mechanism

• Lisdexamfetamine is a therapeutically inactive molecule until it undergoes hydrolysis in the blood to release d-amphetamine and L-lysine, with conversion occurring through rate-limited enzymatic hydrolysis rather than pH-dependent passive diffusion 3, 4

• The prodrug design means that lisdexamfetamine must be absorbed intact from the gastrointestinal tract before conversion to active amphetamine occurs systemically 3, 4

• Alternative routes of administration (including manipulation of gastric pH) do not bypass the requirement for enzymatic conversion, making Vyvanse resistant to the absorption-enhancement effects seen with immediate-release amphetamines 3

Pharmacokinetic Comparison

• Lisdexamfetamine reaches peak plasma amphetamine levels approximately 1.1 hours later than immediate-release d-amphetamine (mean lag time 0.6 hours longer), but maximal concentrations and total exposure (AUC) remain equivalent once conversion occurs 5

• The rate-limited hydrolysis provides sustained therapeutic coverage throughout the day with a single morning dose, independent of gastric pH fluctuations 3

• No differences in maximal amphetamine concentrations or total bioavailability were observed between lisdexamfetamine and d-amphetamine in controlled studies, indicating that the prodrug conversion is complete and pH-independent 5

---

Clinical Implications and Monitoring

For Adderall Users

• Patients taking Adderall should avoid concurrent use of antacids, sodium bicarbonate, or other alkalinizing agents within 1–2 hours of dosing to prevent unpredictable increases in amphetamine absorption 1

• Acidic foods and beverages (citrus juices, vitamin C supplements) may reduce Adderall efficacy by decreasing absorption and increasing urinary elimination 1

• Gastric pH alterations can cause significant variability in amphetamine plasma concentrations, contributing to inconsistent therapeutic response or unexpected adverse effects 6, 2

For Vyvanse Users

• Vyvanse provides more consistent pharmacokinetics regardless of gastric pH because absorption of the intact prodrug precedes enzymatic activation 3, 4

• The prodrug design eliminates the need for dietary pH management, offering a practical advantage for patients who require concurrent antacid therapy or have variable gastric acidity 3, 4

Common Pitfall to Avoid

• Do not assume that all amphetamine formulations are equally affected by gastric pH—immediate-release and mixed-salt formulations (Adderall) are highly pH-sensitive, whereas prodrug formulations (Vyvanse) are protected from these interactions 3, 1, 4

• Gastric emptying rate also influences absorption kinetics for both medications, with faster emptying generally increasing the rate (but not necessarily extent) of absorption for Adderall, while having minimal impact on Vyvanse's rate-limited conversion 6, 7